Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Recurrent violence linked to substantially higher rates of mental disorders in post-conflict communities

  • Luck affects how we judge reckless actions

  • Motor skill deficiencies linked to autism severity, reseearch says

  • New ultrasound device may add in detecting risk for heart attack, stroke

  • Leaders call for expanded use of medications to combat opioid overdose epidemic

  • Take notes by hand for better long-term comprehension

  • Paying closer attention to attention

  • Small business owners not always worried about being treated fairly, researcher finds

  • Fruitfly study identifies brain circuit that drives daily cycles of rest, activity

  • New genetic brain disorder in humans discovered

  •